A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers
Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia.
Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers.
Dr. Haishan Zeng receives CIHR project grant of $711,451 for “Multiphoton Photothermolysis Based Laser Therapy for Precision Treatment of Neovascular Eye Diseases”
Dr. Andrew Minchinton receives CIHR project grant of $573,750 for “Hypoxia-activated DNA Repair Inhibitors to Improve Cancer Therapy”
Congratulations to Dr. Andrew Minchinton for receiving a CIHR project grant of $573,750 for “Hypoxia-activated DNA Repair Inhibitors to Improve Cancer Therapy”.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.